Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul;169(7):e70148.
doi: 10.1111/jnc.70148.

Milestone Review: The History of Molecular Genetics Analysis of Alzheimer's Disease

John Hardy  1
Affiliations
Review

Milestone Review: The History of Molecular Genetics Analysis of Alzheimer's Disease

John Hardy. J Neurochem. 2025 Jul.

Abstract

Alzheimer research has been driven by genetic findings: from the 1990s until about 2005, by the identification of amyloid precursor protein (APP) and presenilin (PSEN) mutations, leading to the formulation of the amyloid hypothesis, and then from ~2007 by genome-wide studies which have led to the increasing appreciation of the importance of microglial insufficiency in the disease pathogenesis. These genome findings have led not only to key mechanistic insights but also to progress in the use of genetic data to predict those at high risk of the disease so that earlier treatment becomes more practical. In this review I will outline these developments and attempts to synthesise the findings into a coherent single view of the disease.

Keywords: Alzheimer; amyloid; genetic.

PubMed Disclaimer

Conflict of interest statement

I have received funding for consulting with Eisai and Eli Lilly.

References

    1. Altmann, A. , Aksman L. M., Oxtoby N. P., et al. 2024. “Towards Cascading Genetic Risk in Alzheimer's Disease.” Brain 147, no. 8: 2680–2690. - PMC - PubMed
    1. Álvarez Jerez, P. , Wild Crea P., Ramos D. M., et al. 2024. “African Ancestry Neurodegeneration Risk Variant Disrupts an Intronic Branchpoint in GBA1.” Nature Structural & Molecular Biology 31, no. 12: 1955–1963. - PMC - PubMed
    1. Corder, E. H. , Saunders A. M., Strittmatter W. J., et al. 1993. “Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families.” Science 261, no. 5123: 921–923. - PubMed
    1. Cukier, H. N. , Kunkle B. W., Vardarajan B. N., et al. 2016. “ABCA7 Frameshift Deletion Associated With Alzheimer Disease in African Americans.” Neurology Genetics 2, no. 3: e79. 10.1212/NXG.0000000000000079. - DOI - PMC - PubMed
    1. Escott‐Price, V. , and Hardy J.. 2022. “Genome‐Wide Association Studies for Alzheimer's Disease: Bigger Is Not Always Better.” Brain Communications 4, no. 3: fcac125. 10.1093/braincomms/fcac125. - DOI - PMC - PubMed

Substances